Maher Alesali, MD
Endocrinology, Diabetes & Metabolism · White Hall, ARNPI 1801901509
Payments from drug & device makers
Across 1,084 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- AstraZeneca$2K
- Lilly USA, LLC$2K
- Boehringer Ingelheim$2K
- Corcept Therapeutics$2K
- Dexcom, Inc.$1K
- plus $7K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 206 | $2,815 |
| AstraZeneca(2 entities) | 102 | $2,148 |
| Lilly USA, LLC | 112 | $1,904 |
| Boehringer Ingelheim | 119 | $1,804 |
| Corcept Therapeutics | 86 | $1,556 |
| Dexcom, Inc. | 86 | $1,347 |
| Sanofi-aventis U.S. LLC | 62 | $1,001 |
| Amgen(2 entities) | 33 | $721 |
| Bayer | 40 | $684 |
| Xeris Pharmaceuticals, Inc. | 38 | $631 |
| Amarin Pharma, Inc. | 40 | $627 |
| Merck | 42 | $551 |
| Johnson & Johnson | 28 | $500 |
| AbbVie | 19 | $456 |
| Medtronic | 11 | $194 |
| Abbott | 11 | $184 |
| Ascendis Pharma Endocrinology Inc | 3 | $165 |
| Sequel Med Tech, LLC | 3 | $152 |
| Insulet Corporation | 8 | $141 |
| Shire North American Group Inc | 9 | $124 |
| Cequr Corporation | 3 | $109 |
| Radius Health, Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Tandem Diabetes Care, Inc. | 2 | $31 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| IBSA Pharma Inc. | 2 | $29 |
| Lifescan, Inc. | 2 | $24 |
| Cardiva Medical, Inc. | 1 | $22 |
| BETA Bionics, Inc. | 1 | $22 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Nevro Corp. | 1 | $17 |
| Novartis | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
How this compares
$18,193 in reported general payments places this provider in the 60th percentile of 43 endocrinology, diabetes & metabolism providers in Arkansas.
See all endocrinology, diabetes & metabolism providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in White Hall
- James ThrasherLittle Rock$4M
- Richard GriffithsLittle Rock$925K
- Catherine KilpatrickFayetteville$690K
- Adam MaassSpringdale$502K
- Madhu BudhrajaLittle Rock$461K
- Kevin GanongJonesboro$131K
- Cory GambleFort Smith$112K
- Irina LendelLittle Rock$87K
- Chitharanjan DuvoorJonesboro$76K
- Donald BodennerLittle Rock$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.